scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41409-018-0330-2 |
P698 | PubMed publication ID | 30171223 |
P50 | author | Kazuaki Kameda | Q86108563 |
Jin Hayakawa | Q91254523 | ||
Yu Akahoshi | Q38641929 | ||
Kana Sakamoto | Q59684858 | ||
P2093 | author name string | Machiko Kusuda | |
Ayumi Gomyo | |||
Hideki Nakasone | |||
Hidenori Wada | |||
Kiriko Terasako-Saito | |||
Koji Kawamura | |||
Miki Sato | |||
Misato Kikuchi | |||
Shinichi Kako | |||
Shun-Ichi Kimura | |||
Tomotaka Ugai | |||
Yoshinobu Kanda | |||
Yuko Ishihara | |||
Kazuki Yoshimura | |||
Aki Tanihara | |||
Masaharu Tamaki | |||
Yukiko Misaki | |||
P2860 | cites work | Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 |
Regimen-related toxicity in patients undergoing bone marrow transplantation | Q70215525 | ||
Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD | Q73372633 | ||
Acute graft-versus-host disease does not require alloantigen expression on host epithelium | Q74221421 | ||
Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation | Q81079571 | ||
Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation | Q82224325 | ||
Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients | Q82231770 | ||
Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse | Q82363808 | ||
Diagnosis and management of acute graft-versus-host disease | Q83992372 | ||
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation | Q33718837 | ||
Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia | Q33857573 | ||
Reciprocal interactions of the intestinal microbiota and immune system. | Q34033579 | ||
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america | Q34160380 | ||
Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated | Q34626390 | ||
How I treat refractory acute GVHD. | Q35828633 | ||
Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation. | Q36289007 | ||
Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease | Q36357597 | ||
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis | Q36392617 | ||
Interleukin-6 and the acute phase response | Q36559880 | ||
How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver. | Q36727862 | ||
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. | Q36835126 | ||
Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients | Q36961081 | ||
Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. | Q37152028 | ||
Pro-inflammatory mechanisms in sepsis | Q37887361 | ||
The role of the immune system in governing host-microbe interactions in the intestine | Q38115440 | ||
Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. | Q38483410 | ||
The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review | Q38829335 | ||
Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients | Q38964217 | ||
High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation. | Q40137330 | ||
The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation | Q40333157 | ||
Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. | Q40413348 | ||
Investigation of the freely available easy-to-use software 'EZR' for medical statistics | Q41513106 | ||
Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning | Q43198292 | ||
Pre-engraftment blood stream infection is a risk factor for acute GVHD grades II-IV. | Q43789729 | ||
Cyclooxygenase-2 is induced in brain blood vessels during fever evoked by peripheral or central administration of tumor necrosis factor | Q48462356 | ||
Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. | Q51169431 | ||
Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin. | Q51780256 | ||
Neural Mechanisms of Inflammation-Induced Fever | Q58314745 | ||
P433 | issue | 5 | |
P304 | page(s) | 707-716 | |
P577 | publication date | 2018-08-31 | |
P1433 | published in | Bone Marrow Transplantation | Q4941523 |
P1476 | title | Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation | |
P478 | volume | 54 |
Search more.